4.5 Article

Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Targeting Notch signaling pathway in cancer: Clinical development advances and challenges

Naoko Takebe et al.

PHARMACOLOGY & THERAPEUTICS (2014)

Article Pharmacology & Pharmacy

TGF-β as a therapeutic target in high grade gliomas - Promises and challenges

Justin V. Joseph et al.

BIOCHEMICAL PHARMACOLOGY (2013)

Article Oncology

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

Mark R. Gilbert et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Multidisciplinary Sciences

Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3

Ping Mao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Cell & Tissue Engineering

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells

Kaushal Joshi et al.

STEM CELLS (2013)

Article Oncology

The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models

Masamichi Mizuma et al.

MOLECULAR CANCER THERAPEUTICS (2012)

Article Biochemistry & Molecular Biology

Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer

M. Kondratyev et al.

ONCOGENE (2012)

Review Oncology

Glioma-initiating cells and molecular pathology: implications for therapy

Atsushi Natsume et al.

BRAIN TUMOR PATHOLOGY (2011)

Article Oncology

NKX2.2 Suppresses Self-Renewal of Glioma-Initiating Cells

Teruyuki Muraguchi et al.

CANCER RESEARCH (2011)

Review Neurosciences

Not(ch) just development: Notch signalling in the adult brain

Jessica L. Ables et al.

NATURE REVIEWS NEUROSCIENCE (2011)

Article Multidisciplinary Sciences

A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations

Xiaowei Yan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Oncology

Notch signalling in solid tumours: a little bit of everything but not all the time

Prathibha Ranganathan et al.

NATURE REVIEWS CANCER (2011)

Article Oncology

The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo

Peng Xu et al.

JOURNAL OF NEURO-ONCOLOGY (2010)

Review Oncology

The functional role of Notch signaling in human gliomas

Marie-Therese Stockhausen et al.

NEURO-ONCOLOGY (2010)

Article Multidisciplinary Sciences

Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin

Akira Tamase et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Medicine, Research & Experimental

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas

Kyeung Min Joo et al.

LABORATORY INVESTIGATION (2008)

Review Medicine, General & Internal

Malignant gliomas in adults

Patrick Y. Wen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Clinical Neurology

The 2007 WHO classification of tumours of the central nervous system

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2007)

Article Clinical Neurology

Contribution of Notch signaling activation to human glioblastoma multiforme

Masayuki Kanamori et al.

JOURNAL OF NEUROSURGERY (2007)

Review Cell Biology

Crossing paths with Notch in the hyper-network

Gregory D. Hurlbut et al.

CURRENT OPINION IN CELL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma

Gentao Liu et al.

MOLECULAR CANCER (2006)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)